New Drug Approved in the Fight Against Lung Cancer
Posted on March 4, 2015
Today marks a really momentous milestone for the fight against lung cancer, with a new drug, Opdivo by Bristol-Myers Squibb, that has nearly doubled the survival rates in clinical trials. This is why we do what we do at the Goodson Classic, and why we’re all about H.O.P.E. — Having Optimism Present Every Day. Find out more by clicking here.